U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06920212) titled 'Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease' on March 31.

Brief Summary: To investigate the clinical safety and efficacy of FMT in AD patients, as well as the changes in the gut microbiota of AD patients before and after FMT.

Study Start Date: Oct. 01, 2024

Study Type: INTERVENTIONAL

Condition: Fecal Microbiota Transplantation

Intervention: PROCEDURE: FMT capsule

Fecal microbiota transplantation (FMT) is a method for treating imbalances in the intestinal microbiota. Its basic principle involves extracting a portion of feces from a healthy individual that cont...